chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Doesn't think she got the full dose either time/underdosed/only received 5cm of the Moderna Covid-19 vaccine each dose; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Doesn't think she got the full dose either time/underdosed/only received 5cm of the Moderna Covid-19 vaccine each dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced UNDERDOSE (Doesn't think she got the full dose either time/underdosed/only received 5cm of the Moderna Covid-19 vaccine each dose). At the time of the report, UNDERDOSE (Doesn't think she got the full dose either time/underdosed/only received 5cm of the Moderna Covid-19 vaccine each dose) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       Patient stated that she only received 5cm of the Moderna COVID-19 vaccine for each dose. Concomitant product use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-090494 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28-Jun-2021 contain significant information.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cervicobrachial syndrome, Fatigue, Headache, Pain, Vaccination site erythema
Clinical narrative: patient woke up achy; hardness of arm; redness in between elbow, up the arm, to shoulder and neck; arm red and hot to touch; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site oedema
Clinical narrative: patient woke up achy; hardness of arm; redness in between elbow, up the arm, to shoulder and neck; arm red and hot to touch; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch) and HEADACHE (headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, PAIN (patient woke up achy), VACCINATION SITE OEDEMA (hardness of arm), CERVICOBRACHIAL SYNDROME (redness in between elbow, up the arm, to shoulder and neck), VACCINATION SITE ERYTHEMA (arm red and hot to touch), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 43 days apart for second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (43 days apart for second dose) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (43 days apart for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (43 days apart for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Underdose
Clinical narrative: doesn't think she got the full dose either time; underdosed; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (doesn't think she got the full dose either time) and UNDERDOSE (underdosed) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 043B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced INCORRECT DOSE ADMINISTERED (doesn't think she got the full dose either time) and UNDERDOSE (underdosed). On 27-Mar-2021, INCORRECT DOSE ADMINISTERED (doesn't think she got the full dose either time) and UNDERDOSE (underdosed) had resolved. Not Provided          Patient reported that she received both the doses of Moderna vaccine but was under dose both the time, She wanted to know if she can get vaccinate again with full dose.  Concomitant product use was not provided by the reporter.   ? No treatment information was provided.   This case was linked to MOD-2021-090489 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up information received on 08-JUN-2021 contains significant information: Added New Event  (Underdose) On 28-Jun-2021: Non-Significant Follow up Appended - Reporter mail address updated
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Peripheral swelling, Vaccination site rash
Clinical narrative: swollen arm; like lyme disease; like bull's-eye; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), VACCINATION SITE RASH (like lyme disease) and INJECTION SITE SWELLING (like bull's-eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), VACCINATION SITE RASH (like lyme disease) and INJECTION SITE SWELLING (like bull's-eye). At the time of the report, PERIPHERAL SWELLING (swollen arm), VACCINATION SITE RASH (like lyme disease) and INJECTION SITE SWELLING (like bull's-eye) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Medical History information was reported. Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MODERNATX, INC.-MOD-2021-090348, MODERNATX, INC.-MOD-2021-023899, MODERNATX, INC.-MOD-2021-030815, MODERNATX, INC.-MOD-2021-090656 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-090348: MODERNATX, INC.-MOD-2021-023899: MODERNATX, INC.-MOD-2021-030815: MODERNATX, INC.-MOD-2021-090656:cross linked case
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: it's not as itchy as before; it is still red; She also reports that redness also started at the same time; She started with itching at the injection site within few hours after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it's not as itchy as before), ERYTHEMA (it is still red), VACCINATION SITE ERYTHEMA (She also reports that redness also started at the same time) and VACCINATION SITE PRURITUS (She started with itching at the injection site within few hours after receiving 1st dose) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (She also reports that redness also started at the same time) and VACCINATION SITE PRURITUS (She started with itching at the injection site within few hours after receiving 1st dose). On 26-Apr-2021, the patient experienced PRURITUS (it's not as itchy as before) and ERYTHEMA (it is still red). At the time of the report, PRURITUS (it's not as itchy as before), ERYTHEMA (it is still red), VACCINATION SITE ERYTHEMA (She also reports that redness also started at the same time) and VACCINATION SITE PRURITUS (She started with itching at the injection site within few hours after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes allergic medicines No Treatment information was reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pre-existing condition improved
Clinical narrative: after his 2nd dose his COPD improved, as far as his breathing goes; This spontaneous case was reported by a consumer and describes the occurrence of PRE-EXISTING CONDITION IMPROVED (after his 2nd dose his COPD improved, as far as his breathing goes) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included Panic attacks and COPD. Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRE-EXISTING CONDITION IMPROVED (after his 2nd dose his COPD improved, as far as his breathing goes). At the time of the report, PRE-EXISTING CONDITION IMPROVED (after his 2nd dose his COPD improved, as far as his breathing goes) outcome was unknown.            No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Abdominal discomfort, Arthralgia, Asthenia, Malaise, Musculoskeletal stiffness
Clinical narrative: Malaise; Low energy level; Tenderness around right armpit of upperarm, chest and in armpit; Stiffness, shoulder stiff; muscular and joint ache and pains, Knee soreness; Muscular aches and pains, soreness in arm and shoulder; Intestinal distress; Drowsiness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (muscular and joint ache and pains, Knee soreness), MYALGIA (Muscular aches and pains, soreness in arm and shoulder), SOMNOLENCE (Drowsiness), ABDOMINAL DISCOMFORT (Intestinal distress) and MALAISE (Malaise) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B214 and 081L2014) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product COFFEA ARABICA, PHOSPHATIDYL SERINE (NEURIVA BRAIN PERFORMANCE) for an unknown indication.    The patient's past medical history included COVID-19. Concomitant products included FLUOXETINE for Anxiety, ROSUVASTATIN CALCIUM (CRESTOR), ROSUVASTATIN, MULTIVITAMIN [VITAMINS NOS], VITAMIN D3 and CYANOCOBALAMIN (VITAMIN B-12) for an unknown indication.   In 2020, the patient started COFFEA ARABICA, PHOSPHATIDYL SERINE (NEURIVA BRAIN PERFORMANCE) (unknown route) 1 dosage form. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced SOMNOLENCE (Drowsiness). On 03-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Intestinal distress). On 05-Apr-2021, the patient experienced ARTHRALGIA (muscular and joint ache and pains, Knee soreness) and MYALGIA (Muscular aches and pains, soreness in arm and shoulder). On 24-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness, shoulder stiff). On an unknown date, the patient experienced MALAISE (Malaise), ASTHENIA (Low energy level) and TENDERNESS (Tenderness around right armpit of upperarm, chest and in armpit). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, ARTHRALGIA (muscular and joint ache and pains, Knee soreness), MYALGIA (Muscular aches and pains, soreness in arm and shoulder), SOMNOLENCE (Drowsiness), ABDOMINAL DISCOMFORT (Intestinal distress), MALAISE (Malaise), ASTHENIA (Low energy level), MUSCULOSKELETAL STIFFNESS (Stiffness, shoulder stiff) and TENDERNESS (Tenderness around right armpit of upperarm, chest and in armpit) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: significant follow up
Age: 73.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Myalgia, Somnolence, Tenderness
Clinical narrative: Malaise; Low energy level; Tenderness around right armpit of upperarm, chest and in armpit; Stiffness, shoulder stiff; muscular and joint ache and pains, Knee soreness; Muscular aches and pains, soreness in arm and shoulder; Intestinal distress; Drowsiness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Apr-2021 and was forwarded to Moderna on 26-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (muscular and joint ache and pains, Knee soreness), MYALGIA (Muscular aches and pains, soreness in arm and shoulder), SOMNOLENCE (Drowsiness), ABDOMINAL DISCOMFORT (Intestinal distress) and MALAISE (Malaise) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B214 and 081L2014) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product COFFEA ARABICA, PHOSPHATIDYL SERINE (NEURIVA BRAIN PERFORMANCE) for an unknown indication.    The patient's past medical history included COVID-19. Concomitant products included FLUOXETINE for Anxiety, ROSUVASTATIN CALCIUM (CRESTOR), ROSUVASTATIN, MULTIVITAMIN [VITAMINS NOS], VITAMIN D3 and CYANOCOBALAMIN (VITAMIN B-12) for an unknown indication.   In 2020, the patient started COFFEA ARABICA, PHOSPHATIDYL SERINE (NEURIVA BRAIN PERFORMANCE) (unknown route) 1 dosage form. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced SOMNOLENCE (Drowsiness). On 03-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Intestinal distress). On 05-Apr-2021, the patient experienced ARTHRALGIA (muscular and joint ache and pains, Knee soreness) and MYALGIA (Muscular aches and pains, soreness in arm and shoulder). On 24-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness, shoulder stiff). On an unknown date, the patient experienced MALAISE (Malaise), ASTHENIA (Low energy level) and TENDERNESS (Tenderness around right armpit of upperarm, chest and in armpit). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, ARTHRALGIA (muscular and joint ache and pains, Knee soreness), MYALGIA (Muscular aches and pains, soreness in arm and shoulder), SOMNOLENCE (Drowsiness), ABDOMINAL DISCOMFORT (Intestinal distress), MALAISE (Malaise), ASTHENIA (Low energy level), MUSCULOSKELETAL STIFFNESS (Stiffness, shoulder stiff) and TENDERNESS (Tenderness around right armpit of upperarm, chest and in armpit) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: significant follow up
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed second dose (past 36 days with no second dose); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose (past 36 days with no second dose)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose (past 36 days with no second dose)). On 26-Apr-2021, PRODUCT DOSE OMISSION ISSUE (Missed second dose (past 36 days with no second dose)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment information was reported.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Peripheral swelling, Rash, Swelling face, Urticaria
Clinical narrative: swollen face; Swollen hands,swollen feet; Hot flashes; Hives all over the body; Rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (swollen face), PERIPHERAL SWELLING (Swollen hands,swollen feet), HOT FLUSH (Hot flashes), URTICARIA (Hives all over the body) and RASH (Rash all over the body) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. V032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (swollen face), PERIPHERAL SWELLING (Swollen hands,swollen feet), HOT FLUSH (Hot flashes), URTICARIA (Hives all over the body) and RASH (Rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWELLING FACE (swollen face), HOT FLUSH (Hot flashes), URTICARIA (Hives all over the body) and RASH (Rash all over the body) outcome was unknown and PERIPHERAL SWELLING (Swollen hands,swollen feet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. Treatment activities for event was also done with  Steroid medication.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment drugs were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Heart rate, Product dose omission issue
Clinical narrative: Passed the time period for getting the second dose; Pain in joints of lower legs; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Passed the time period for getting the second dose) and ARTHRALGIA (Pain in joints of lower legs) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Passed the time period for getting the second dose) and ARTHRALGIA (Pain in joints of lower legs). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Passed the time period for getting the second dose) and ARTHRALGIA (Pain in joints of lower legs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: elevated (High) Elevated BP. On an unknown date, Heart rate: increased (High) Racing Heartbeat.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include medicines for blood pressure. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Ear pain, Tinnitus, Vaccination site reaction
Clinical narrative: laying down is worst than sitting up; Covid arm; ringing in the ear; pain in her right ear; dizziness got worse; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness got worse), DISCOMFORT (laying down is worst than sitting up), TINNITUS (ringing in the ear), EAR PAIN (pain in her right ear) and VACCINATION SITE REACTION (Covid arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 032M20A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo since January 2020, Seasonal allergy, Penicillin allergy, Tetanus and Allergy to molds. Concomitant products included PRAVASTATIN from 15-Feb-2010 to an unknown date for Cholesterol, BIOTIN from 01-Jan-2012 to an unknown date and VITAMIN B12 NOS from 01-Jan-2015 to an unknown date for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced DIZZINESS (dizziness got worse). On 25-Apr-2021, the patient experienced TINNITUS (ringing in the ear) and EAR PAIN (pain in her right ear). On an unknown date, the patient experienced DISCOMFORT (laying down is worst than sitting up) and VACCINATION SITE REACTION (Covid arm). On 31-May-2021, DIZZINESS (dizziness got worse) was resolving. On 01-Jun-2021, TINNITUS (ringing in the ear) had resolved, EAR PAIN (pain in her right ear) outcome was unknown. At the time of the report, DISCOMFORT (laying down is worst than sitting up) and VACCINATION SITE REACTION (Covid arm) was resolving. Not Provided     This case was linked to MOD-2021-090477 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: from the follow up VARES form is attached, additional AE for dose 2, AE outcome; pt also included description for dose 1 AE; conmeds
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Adnexa uteri pain, Anxiety, Back pain, Flatulence
Clinical narrative: Anxious; Pain in ovaries; Pain on waist that extended to back; Pain on leg; Stomach full of gases; Stomach swollen; Her feet cold and sweaty; Feet cold and sweaty; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen) and PERIPHERAL COLDNESS (Her feet cold and sweaty) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen), PERIPHERAL COLDNESS (Her feet cold and sweaty) and HYPERHIDROSIS (Feet cold and sweaty). On an unknown date, the patient experienced ANXIETY (Anxious) and ADNEXA UTERI PAIN (Pain in ovaries). At the time of the report, BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen), PERIPHERAL COLDNESS (Her feet cold and sweaty), HYPERHIDROSIS (Feet cold and sweaty), ANXIETY (Anxious) and ADNEXA UTERI PAIN (Pain in ovaries) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.     Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain in extremity, Peripheral coldness
Clinical narrative: Anxious; Pain in ovaries; Pain on waist that extended to back; Pain on leg; Stomach full of gases; Stomach swollen; Her feet cold and sweaty; Feet cold and sweaty; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen) and PERIPHERAL COLDNESS (Her feet cold and sweaty) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen), PERIPHERAL COLDNESS (Her feet cold and sweaty) and HYPERHIDROSIS (Feet cold and sweaty). On an unknown date, the patient experienced ANXIETY (Anxious) and ADNEXA UTERI PAIN (Pain in ovaries). At the time of the report, BACK PAIN (Pain on waist that extended to back), PAIN IN EXTREMITY (Pain on leg), FLATULENCE (Stomach full of gases), ABDOMINAL DISTENSION (Stomach swollen), PERIPHERAL COLDNESS (Her feet cold and sweaty), HYPERHIDROSIS (Feet cold and sweaty), ANXIETY (Anxious) and ADNEXA UTERI PAIN (Pain in ovaries) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.     Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warmth around injection site; swollen injection site; redness around of injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH, VACCINATION SITE SWELLING, and VACCINATION SITE ERYTHEMA in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history information was reported.     On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE WARMTH, VACCINATION SITE SWELLING, and VACCINATION SITE ERYTHEMA. The patient was treated with PARACETAMOL at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH, VACCINATION SITE SWELLING, and VACCINATION SITE ERYTHEMA outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PYREXIA (Fever). On 28-Mar-2021, PYREXIA (Fever) had resolved. Not Provided    mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-090520 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm after 1st dose) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 041B21A) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included LACTOBACILLUS NOS (CULTURELLE) and AMBEREN for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced MYALGIA (sore arm after 1st dose). On 28-Mar-2021, MYALGIA (sore arm after 1st dose) had resolved.            no treatment product was reported.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-090536, US-MODERNATX, INC.-MOD-2021-090151 (Linked Report). This case was linked to MOD-2021-090143 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090536:Case for dose 2 US-MODERNATX, INC.-MOD-2021-090151:cross linked case
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue, Wrong technique in product usage process
Clinical narrative: One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion; One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (One of the vials was administered to a patient after the Pharmacist confirmed Temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment information provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Insomnia, Pain, Peripheral swelling, Vaccination site infection
Clinical narrative: swollen left whole arm; injection site was infected; pain all over the arm moving up to the tip of left hand; injection arm soreness; injection arm numbness; Couldn't able to sleep on the left side due to pain"; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain"), PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected) and PAIN (pain all over the arm moving up to the tip of left hand) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reported.  Concomitant products included LORATADINE for Allergy, FLUTICASONE PROPIONATE and BUDESONIDE;FORMOTEROL for Asthma, DULAGLUTIDE (TRULICITY) for Diabetes.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain") and VACCINATION SITE PAIN (injection arm soreness). On 25-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected) and PAIN (pain all over the arm moving up to the tip of left hand). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain"), PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected), PAIN (pain all over the arm moving up to the tip of left hand) and VACCINATION SITE PAIN (injection arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included Antibiotics treatment but not started yet.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: swollen left whole arm; injection site was infected; pain all over the arm moving up to the tip of left hand; injection arm soreness; injection arm numbness; Couldn't able to sleep on the left side due to pain"; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain"), PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected) and PAIN (pain all over the arm moving up to the tip of left hand) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reported.  Concomitant products included LORATADINE for Allergy, FLUTICASONE PROPIONATE and BUDESONIDE;FORMOTEROL for Asthma, DULAGLUTIDE (TRULICITY) for Diabetes.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain") and VACCINATION SITE PAIN (injection arm soreness). On 25-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected) and PAIN (pain all over the arm moving up to the tip of left hand). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (injection arm numbness), INSOMNIA (Couldn't able to sleep on the left side due to pain"), PERIPHERAL SWELLING (swollen left whole arm), VACCINATION SITE INFECTION (injection site was infected), PAIN (pain all over the arm moving up to the tip of left hand) and VACCINATION SITE PAIN (injection arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included Antibiotics treatment but not started yet.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and rash (all over the body) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 03B21A) for COVID-19 vaccination. Concomitant products included Trileptal (oxcarbazepine), Klonopin (clonazepam), naproxen and omeprazole for an unknown indication. On Apr 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain in extremity (sore arm) and rash (all over the body). At the time of the report, pain in extremity (sore arm) and rash (all over the body) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or treatment medication.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity, Pruritus, Rash, Vaccination site rash
Clinical narrative: chest pain for one day; itchy; painful; "Moderna rash" on the injection arm; red spot the size of less than a hand; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine). The report describes a case of CHEST PAIN (chest pain for one day), PRURITUS (itchy), PAIN IN EXTREMITY (painful), VACCINATION SITE RASH ("Moderna rash" on the injection arm) and RASH (red spot the size of less than a hand).     No Medical History information was reported.  On 12-Apr-2021, the patient experienced CHEST PAIN (chest pain for one day), PRURITUS (itchy), PAIN IN EXTREMITY (painful), VACCINATION SITE RASH ("Moderna rash" on the injection arm) and RASH (red spot the size of less than a hand). At the time of the report, CHEST PAIN (chest pain for one day), PRURITUS (itchy), PAIN IN EXTREMITY (painful), VACCINATION SITE RASH ("Moderna rash" on the injection arm) and RASH (red spot the size of less than a hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, SARS-CoV-2 antibody test
Clinical narrative: antibody test (IgG and IgM Immunoassay) negative 3 months after being fully vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (antibody test) negative 3 months after being fully vaccinated in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced ANTIBODY TEST NEGATIVE (antibody test negative 3 months after being fully vaccinated. At the time of the report, ANTIBODY TEST NEGATIVE (antibody test negative 3 months after being fully vaccinated, outcome was unknown. Not Provided.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, SARS-CoV-2 antibody test: Positive. In April 2021, SARS-CoV-2 antibody test: Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not reported. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above included, On 27-May-2021 Follow- up received on 27-May-21. January Lab Report Uploaded.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Skin reaction, Tenderness
Clinical narrative: arm is tender; delayed reaction of redness in the arms; redness in the arms; arm is itching; arm hurt; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (redness in the arms), PRURITUS (arm is itching), PAIN IN EXTREMITY (arm hurt), TENDERNESS (arm is tender) and SKIN REACTION (delayed reaction of redness in the arms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced ERYTHEMA (redness in the arms), PRURITUS (arm is itching), PAIN IN EXTREMITY (arm hurt), TENDERNESS (arm is tender) and SKIN REACTION (delayed reaction of redness in the arms). At the time of the report, ERYTHEMA (redness in the arms), PRURITUS (arm is itching), PAIN IN EXTREMITY (arm hurt), TENDERNESS (arm is tender) and SKIN REACTION (delayed reaction of redness in the arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: 1ml of vaccine is given instead of 0.5ml; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL OVERDOSE (1ml of vaccine is given instead of 0.5ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (1ml of vaccine is given instead of 0.5ml). At the time of the report, ACCIDENTAL OVERDOSE (1ml of vaccine is given instead of 0.5ml) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Anger, Vaccination complication
Clinical narrative: One thing after another/problems; was getting angry; Bad abdominal pain after first dose; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Bad abdominal pain after first dose), VACCINATION COMPLICATION (One thing after another/problems) and ANGER (was getting angry) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037KZOA) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had COVID in January.) in January 2021 and Hair loss (The patient noticed hair started falling off when she brushes it.).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced ABDOMINAL PAIN (Bad abdominal pain after first dose). On an unknown date, the patient experienced VACCINATION COMPLICATION (One thing after another/problems) and ANGER (was getting angry). At the time of the report, ABDOMINAL PAIN (Bad abdominal pain after first dose), VACCINATION COMPLICATION (One thing after another/problems) and ANGER (was getting angry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that she was on lot of concomitant medications but declined to mention any of them. No treatment information was provided.   This case was linked to MOD-2021-090544 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received on 27 May 2021 added a new event. On 03-Aug-2021: Significant follow-up: Event added.